NYSE:PFEPharmaceuticals
Pfizer Eliquis Price Move With Cost Plus Raises Questions On Valuation
Pfizer and Bristol Myers Squibb are partnering with Mark Cuban's Cost Plus Drug Company to offer Eliquis directly to cash-paying patients on CostPlusDrugs.com.
The move centers on improving access and price transparency for the oral anticoagulant, one of the most widely used branded blood thinners.
This collaboration marks a shift in how a major biopharma alliance is willing to distribute a branded drug to reach cost-sensitive patients.
For investors watching Pfizer, NYSE:PFE, this...